Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Patent
1994-05-03
1997-06-17
Chambers, Jasemine C.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
435 6, 435 701, 4351723, 435 71, 435375, G01N 3353, C12Q 168, C12P 2102, C12N 1509, C12N 510
Patent
active
056395922
DESCRIPTION:
BRIEF SUMMARY
This invention relates to steroid hormones, steroid hormone-like compounds, steroid hormone receptors, steroid hormone-like receptors, and related species. In a particular aspect, this invention relates to processes mediated by steroids and related hormones. In a further aspect, this invention relates to processes mediated by the proto-oncogenic protein complex, AP-1.
BACKGROUND OF THE INVENTION
Steroids and related hormones play an important role in regulating development, differentiation and homeostasis. The hormones exert their regulatory effects by binding to a superfamily of intracellular receptors, which are direct modulators of gene transcription. Mutational analyses of hormone receptors have identified functional domains responsible for transcriptional activation, nuclear localization, DNA binding, and hormone binding.
Hormone receptors can act to both activate transcription, and to repress expression of a variety of genes. It has been postulated that such repression is mediated by binding of the hormone receptor to DNA regulatory sequences, termed negative hormone response elements, thereby displacing transcriptional activators.
It would be desirable to be able to control the degree to which hormones, either directly or indirectly, activate transactivation and/or the degree to which hormones, either directly or indirectly, repress the expression of certain genes, for such purposes as the treatment of disease states, the development of treating agents with reduced incidence of side effects, and so forth.
The AP-1 protein complex is a member of a class of nuclear proteins encoded by proto-oncogenes that have been implicated in diverse aspects of cell growth, differentiation, and development. The AP-1 binding site is recognized by c-Jun homodimers and c-Jun/c-Fos heterodimers. Binding of c-Fos to the AP-1 site is dependent on the formation of heterodimers with c-Jun. Homodimer and heterodimer formation is mediated through non-covalent interactions facilitated by a structure termed the leucine zipper. In addition to imparting positive regulatory effects on several pathways, the AP-1 complex has also been shown to confer negative regulation on several genes.
Up until now, the effect of a given protein on gene regulation has generally been thought to be the result of interaction between the protein and a regulatory element within the promoter region of the gene being regulated. Thus, compounds which exert an effect on more than one pathway are thought to recognize a responsive element which is common to more than one pathway. Consistent with this, Diamond et al., [in Science 249: 1266-1272 (1990)] describe studies employing a "composite" glucocorticoid response element (GRE), which binds selectively in vitro to both glucocorticoid receptor and c-Jun and c-Fos (components of the phorbol ester-activated AP-1 transcription factor). The authors then propose a general model for composite GRE action that requires DNA binding for interaction between receptor (i.e., glucocorticoid receptor) and non-receptor factors (i.e., c-Jun or c-Fos).
Based on the above-described understanding of the mechanism by which regulatory proteins exert their effects, it would not be possible to alter one regulatory effect of a given protein without also altering some other regulatory effects of that protein. Thus, for any beneficial effect achieved by administration of a hormone or hormone analog, there is a strong likelihood that an undesirable side effect will occur, i.e., promotion of undesired processes and/or inhibition of desired processes. Accordingly, there has been no motivation in the art to search for compounds which are capable of disrupting a known pathway without also undesirably impacting other regulatory pathways.
SUMMARY OF THE INVENTION
In accordance with the present invention, we have discovered that hormone receptors and transcription factor, AP-1, can reciprocally repress each other's transcriptional activation activity. Similarly, we have discovered that hormone receptors and transcription factor, AP-1,
REFERENCES:
Doucas et al. (1991) "Unregulated expression of c Jun or c-Fos proteins but not JunD inhibits ostrogen receptor activity in human breast cancer derived cells." EMBO J 10:2237-2245.
Lucibello et al (1990) "Mutual transrepression of Fos and the gluco corticoid receptor: involvement of a Functional domain in Fos which is absent in FosB" EMBO J 9:2827-2834.
Angel et al (1987) "Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated transacting factor", Cell 49: 729-739.
Schule et al. (1991) Cross-compling of signal transduction pathways: zinc finger meats leucine zipper. Trends in Genetics 7:377-381.
Sassone-Corsi et al., "Direct interaction betwen fos and jun nuclear oncoproteins: role of the `leucine zipper` domain" Nature 336:692-695 (1988).
Schule et al., "Jun-Fos and Receptors for Vitamins A and D Recognize a Common Response Element in the Human Osteocalcin Gene" Cell 61:497-504 (1990).
Schule et al., "Functional Antagonism between Oncoprotein c-Jun and the Glucocorticoid Receptor" Cell 62:1217-1226 (1990).
Schule et al., "Retinoic acid is a negative regulator of AP-1-responsive genes" Proc. Natl. Acad. Sci. USA 88:6092-6096 (1991).
Diamond et al., "Transcription Factor Interactions: Selectors of Positive or Negative Regulation from a Single DNA Element" Science 249:1266-1272 (1990).
Jonat et al., "Antitumor Promotion and Antiinflammation: Down-Modulation of AP-1 (Fos/Jun) Activity by Glucocorticoid Hormone" Cell 62:1189-1204 (1990).
Kouzarides and Ziff, "The role of the leucine zipper in the fos-jun interaction" Nature 336:646-651 (1988).
Kruijer et al., "Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein" Nature 312:711-716 (1994).
Lamph, William W., "Cross-Coupling of AP-1 and Intracellular Hormone Receptors" Cancer Cells 3(5):183-185 (1991).
Landschulz et al., "The Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins" Science 240:1759-1764 (1988).
Mitchell et al., "Rapid Induction of the Expression of Proto-oncogene fos during Human Monocytic Differentiation" Cell 40:209-217 (1985).
Mordacq and Linzer, "Co-localization of elements required for phorbol ester stimulation and glucocorticoid repression of proliferin gene expression" Genes & Development 3:760-769 (1989).
Ransone and Verma, "Nuclear Proto-Oncogenes Fos and Jun" Ann. Rev. Cell Biol. 6:539-557 (1990).
Ryder et al., "A gene activated by growth factors is related to the oncogene v-jun" Proc. Natl. Acad. Sci. USA 85:1487-1491 (1988).
Evans Ronald M.
Schule Ronald
Chambers Jasemine C.
Priebe Scott D.
Reiter Stephen E.
The Salk Institute for Biological Studies
LandOfFree
Functional antagonism between proto-oncoprotein c-Jun and hormon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Functional antagonism between proto-oncoprotein c-Jun and hormon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Functional antagonism between proto-oncoprotein c-Jun and hormon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2156892